Syracuse

Home treatment for patients with cancer-associated venous thromboembolism

Archive ouverte

Sanchez, Olivier | Roy, Pierre-Marie | Gaboreau, Yoann | Schmidt, Jeannot | Moustafa, Farès | Benmaziane, Asmahane | Elias, Antoine | Espitia, Olivier | Sevestre, Marie-Antoinette | Couturaud, Francis | Mahé, Isabelle

Edité par CCSD ; Elsevier ; Société française de cardiologie [2008-....] -

International audience. Patients hospitalised with acute venous thromboembolism (VTE), and notably patients with pulmonary embolism, often remain in hospital for extended periods due to the perceived risk of complications. However, several studies have shown that home treatment of selected patients is feasible and safe, with a low incidence of adverse events. This may offer clear benefits for patients’ quality of life, hospital planning and cost to the health service. Nonetheless, there is a need for a VTE risk-stratification tool specifically addressing prognosis in patients with cancer. This may aid in the selection of low-risk patients with cancer and VTE who are suitable for outpatient treatment. Although several prognostic scores have been proposed, we suggest using a pragmatic clinical decision-making tool such as the Hestia criteria for selecting patients for home care in everyday clinical practice. Once patients have been discharged, it is mandatory to monitor patients regularly (we suggest after 3 days, 10 days, 1 month and 3 months, or more frequently if needed) with the involvement of a multidisciplinary team, so that appropriate and timely remedial action can be taken in case of warning signs of complications. If patients are selected carefully and monitored effectively, many patients who experience acute VTE can be cared for safely at home.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion